-
Product Insights
Kukonaho Wind Farm
Kukonaho Wind Farm is an Onshore Wind project located in Northern Ostrobothnia, Finland. The project is owned by TM Voima Oy and is developed by OX2 AB; TM Voima Oy. The project is at the permitting stage. Empower your strategies with our Kukonaho Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
Tuomipera Wind Farm
Tuomipera Wind Farm is an Onshore Wind project located in Northern Ostrobothnia, Finland. The project is owned by TM Voima Tuomipera Oy and is developed by OX2 AB; TM Voima Tuomipera Oy. The project is at the permitting stage. Empower your strategies with our Tuomipera Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vudalimab in Thymic Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vudalimab in Thymic Carcinoma Drug Details: XmAb-717 is under development for the treatment of cervical...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Larotrectinib Sulfate in Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Larotrectinib Sulfate in Ovarian Cancer Drug Details: Larotrectinib Sulfate (Vitrakvi) is a anti-neoplastic agent. It...
-
Product Insights
Alavieska Wind Farm
Alavieska Wind Farm is an Onshore Wind project located in Northern Ostrobothnia, Finland. The project is owned and being developed by TM Voima Oy. The project is at the permitting stage. Empower your strategies with our Alavieska Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Tulu Moya Geothermal Power Plant
Tulu Moya Geothermal Power Plant is a geothermal project located in Oromia, Ethiopia. The project is owned by Meridiam SAS; Reykjavik Geothermal and is developed by TM Geothermal Operations Pvt Ltd. The project is currently under construction. Empower your strategies with our Tulu Moya Geothermal Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CD-388 in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Influenzavirus B Infections Drug Details:CD-388 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Pandemic Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CD-388 in Pandemic Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Pandemic InfluenzaDrug Details:CD-388 is under development for the treatment and prevention...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Seasonal Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CD-388 in Seasonal Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Seasonal Influenza Drug Details:CD-388 is under development for the treatment and...